We are live on ! Find out more
SBFM icon

Sunshine Biopharma
SBFM

3 hedge funds and large institutions have $32.6K invested in Sunshine Biopharma in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.67% more ownership

Funds ownership: 2.49% → 3.17% (+0.67%)

18% less capital inflows, than outflows

Capital inflows: $96K | Capital outflows: $117K

57% less funds holding

Funds holding: 7 → 3 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-4
Holders Change %
-57.14%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$96K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$48.1K
2
Two Sigma Securities
Two Sigma Securities
New York
-$24.4K
3
XTX Topco
XTX Topco
Cayman Islands
-$22.3K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$14K
5
Morgan Stanley
Morgan Stanley
New York
-$6.92K

SBFM Hedge Fund Activity: Q2 2026 in Review

3 of the 8,371 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q2 2026, worth a combined $32.6K — down 74% from $127K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of SBFM and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was Jane Street, opening a new position worth an estimated $96K. The largest seller was Citadel Advisors, exiting entirely with an estimated $48.1K sold.

  • 3 institutional investors held Sunshine Biopharma (SBFM) as of Q2 2026, down from 7 in Q1 2026.
  • Funds reported $32.6K of Sunshine Biopharma stock for Q2 2026, down 74% quarter-over-quarter.
  • 1 fund opened new Sunshine Biopharma positions in Q2 2026 and 5 closed out, a net change of -4 holders.
  • The largest Sunshine Biopharma buyer in Q2 2026 was Jane Street, an estimated $96K added.
  • The largest Sunshine Biopharma seller in Q2 2026 was Citadel Advisors, an estimated $48.1K sold.

Based on aggregated 13F filings for Q2 2026.